This confirmed an earlier report by Julien et al. 11, wherein they revealed there was a significant reduction in both SirT1 mRNA and protein in the parietal cortex of AD patients, and that this reduction correlated with Aβ and tau pathology, and the duration of AD symptoms. The gene discussed is MAPT; the disease is Alzheimer disease.